| scholarly article | Q13442814 |
| P2093 | author name string | Stephen D Barr | |
| Jenna N Kelly | |||
| Clayton J Hattlmann | |||
| P2860 | cites work | The interferon response inhibits HIV particle production by induction of TRIM22 | Q21131598 |
| Genomic analysis of the TRIM family reveals two groups of genes with distinct evolutionary properties | Q21283880 | ||
| RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination | Q22010577 | ||
| CAJAL BODIES: A Long History of Discovery | Q22065410 | ||
| The tripartite motif family identifies cell compartments | Q24291183 | ||
| Unique features of TRIM5alpha among closely related human TRIM family members | Q24323380 | ||
| Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression | Q24324732 | ||
| TRIM family proteins: retroviral restriction and antiviral defence | Q24329175 | ||
| TRIM family proteins and their emerging roles in innate immunity | Q24607229 | ||
| All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction | Q24673961 | ||
| New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors. | Q54547476 | ||
| Expression of the IFN-inducible p53-target gene TRIM22 is down-regulated during erythroid differentiation of human bone marrow. | Q54559872 | ||
| Localization of Staf50, a member of the Ring finger family, to 11p15 by fluorescence in situ hybridization | Q71139519 | ||
| Gene profiling involved in immature CD4+ T lymphocyte responsible for systemic lupus erythematosus | Q81163747 | ||
| B30.2/SPRY domain in tripartite motif-containing 22 is essential for the formation of distinct nuclear bodies | Q39845286 | ||
| Dynamic localization of tripartite motif-containing 22 in nuclear and nucleolar bodies | Q39866541 | ||
| TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus. | Q39883742 | ||
| Microarray analyses of differentially expressed human genes and biological processes in ECV304 cells infected with rubella virus | Q40081485 | ||
| Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages | Q40240821 | ||
| Structure of the PRYSPRY-domain: implications for autoinflammatory diseases | Q40490657 | ||
| Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells. | Q40861585 | ||
| Different subcellular localisations of TRIM22 suggest species-specific function | Q41834429 | ||
| A 5' extended IFN-stimulating response element is crucial for IFN-gamma-induced tripartite motif 22 expression via interaction with IFN regulatory factor-1. | Q42970175 | ||
| Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain | Q45382996 | ||
| Complexity of inflammatory responses in endothelial cells and vascular smooth muscle cells determined by microarray analysis. | Q45969767 | ||
| Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters | Q46803214 | ||
| The pericentromeric region of human chromosome 11: evidence for a chromosome-specific duplication | Q48317259 | ||
| Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease? | Q50513813 | ||
| TRIM proteins and cancer. | Q53280723 | ||
| Type I interferon-dependent and -independent expression of tripartite motif proteins in immune cells. | Q53497217 | ||
| Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection | Q27473003 | ||
| HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages | Q28204428 | ||
| Fifty years of coiled-coils and alpha-helical bundles: a close relationship between sequence and structure | Q28272743 | ||
| Gene duplication: a drive for phenotypic diversity and cause of human disease | Q28294965 | ||
| Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain | Q29618741 | ||
| Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals | Q30839843 | ||
| Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells. | Q33200966 | ||
| A large new subset of TRIM genes highly diversified by duplication and positive selection in teleost fish | Q33406010 | ||
| Human TRIM gene expression in response to interferons | Q33418607 | ||
| Genomic analysis of the host response to hepatitis B virus infection | Q33696514 | ||
| Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31. | Q33803580 | ||
| ENCODE tiling array analysis identifies differentially expressed annotated and novel 5' capped RNAs in hepatitis C infected liver | Q33832050 | ||
| Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction | Q33834617 | ||
| The interferon-inducible Staf50 gene is downregulated during T cell costimulation by CD2 and CD28. | Q33926570 | ||
| Retroviral restriction factor TRIM5alpha is a trimer | Q34123929 | ||
| Two B or not two B? Overview of the rapidly expanding B-box family of proteins | Q34294268 | ||
| A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction | Q34384150 | ||
| Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection | Q34458011 | ||
| The evolution of gene duplicates | Q34586458 | ||
| Regulation of the interferon-inducible p53 target gene TRIM22 (Staf50) in human T lymphocyte activation. | Q34707810 | ||
| The early stages of duplicate gene evolution. | Q34790619 | ||
| Identification of TRIM22 as a RING finger E3 ubiquitin ligase | Q34801157 | ||
| TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements | Q35076765 | ||
| Determinants of the higher order association of the restriction factor TRIM5alpha and other tripartite motif (TRIM) proteins | Q35150045 | ||
| Identification of a genomic reservoir for new TRIM genes in primate genomes | Q35586967 | ||
| TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases | Q36291771 | ||
| Relationship between SPRY and B30.2 protein domains. Evolution of a component of immune defence? | Q36324988 | ||
| Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: involvement of host cellular factors | Q36484112 | ||
| Anti-retroviral activity of TRIM5 alpha | Q37668471 | ||
| The cell biology of TRIM5α. | Q37970939 | ||
| BRG1 is indispensable for IFN-γ-induced TRIM22 expression, which is dependent on the recruitment of IRF-1. | Q39522689 | ||
| Identification of tripartite motif-containing 22 (TRIM22) as a novel NF-κB activator | Q39529044 | ||
| The human IFN-inducible p53 target gene TRIM22 colocalizes with the centrosome independently of cell cycle phase | Q39763992 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 153415 | |
| P577 | publication date | 2012-05-08 | |
| P1433 | published in | Molecular Biology International | Q26841791 |
| P1476 | title | TRIM22: A Diverse and Dynamic Antiviral Protein | |
| P478 | volume | 2012 |
| Q38692134 | Advances in anti-viral immune defence: revealing the importance of the IFN JAK/STAT pathway. |
| Q42215059 | Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFNα-2a and ribavirin in Iranian patients with chronic hepatitis C. |
| Q37648812 | Expression profiling of TRIM protein family in THP1-derived macrophages following TLR stimulation |
| Q41575072 | Highly skewed distribution of miRNAs and proteins between colorectal cancer cells and their exosomes following Cetuximab treatment: biomolecular, genetic and translational implications. |
| Q35199204 | In silico analysis of functional single nucleotide polymorphisms in the human TRIM22 gene |
| Q37222827 | Induction of TRIM22 by IFN-γ Involves JAK and PC-PLC/PKC, but Not MAPKs and pI3K/Akt/mTOR Pathways |
| Q36459126 | Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A. |
| Q34405609 | Interferon-stimulated genes: a complex web of host defenses |
| Q33598835 | Lentivirus-mediated RNA interference of tripartite motif 68 inhibits the proliferation of colorectal cancer cell lines SW1116 and HCT116 in vitro |
| Q42369135 | Long Non-coding RNAs in Hepatitis C Virus-Infected Cells. |
| Q92923865 | Multiplexed Proteomic Approach for Identification of Serum Biomarkers in Hepatocellular Carcinoma Patients with Normal AFP |
| Q39530544 | Phosphoproteomics to Characterize Host Response During Influenza A Virus Infection of Human Macrophages |
| Q37579656 | Regulatory role of TRIM21 in the type-I interferon pathway in Japanese encephalitis virus-infected human microglial cells. |
| Q37230823 | Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients |
| Q24301176 | TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity |
| Q27468655 | TRIM52 inhibits Japanese Encephalitis Virus replication by degrading the viral NS2A |
| Q37713931 | TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment |
| Q38170892 | TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity |
| Q40075519 | The TRIMendous Role of TRIMs in Virus-Host Interactions |
| Q33726203 | The interferon-inducible antiviral protein Daxx is not essential for interferon-mediated protection against avian sarcoma virus. |
| Q47120902 | Tripartite Motif 22 and Class II Transactivator Restriction Factors: Unveiling Their Concerted Action against Retroviruses |
| Q40181655 | Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1. |
| Q35075884 | Upregulation of innate antiviral restricting factor expression in the cord blood and decidual tissue of HIV-infected mothers. |
| Q40533140 | Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease |
| Q39152504 | p300, but not PCAF, collaborates with IRF-1 in stimulating TRIM22 expression independently of its histone acetyltransferase activity |
Search more.